Natus Medical, a pure-play neurodiagnostics company, has acquired the remaining minority shares in Holberg EEG, developer of the world’s first artificial intelligence (AI) model capable of automatic and comprehensive clinical EEG interpretation with accuracy that matches leading medical experts.

Natus now owns 100% of Holberg EEG. The deal combines the Holberg EEG tech with Natus’ neurodiagnostics portfolio to create opportunities to advance brain health with smarter, more accessible solutions.

The company said the Holberg EEG AI model provides unprecedented efficiency and diagnostic confidence for clinicals interpreting complex EEG data, addressing a significant gap in neurological care.

Holberg EEG was founded in 2009 and brings expertise in AI-assisted EEG interpretation. Its flagship autoSCORE tool was introduced in the U.S. market in August 2024. It’s designed to alleviate demands on clinical resources via a deep learning model trained on over 30,000 expertly labeled EEG recordings.

The technology is offered exclusively with Natus NeuroWorks software and is U.S. Food and Drug Administration (FDA) 510(k) cleared for routine EEG, long-term monitoring, and ambulatory EEG studies. It’s also earned CE mark clearance for European and other applicable countries.

“Bringing Holberg EEG into the Natus family is an exciting and strategic milestone for our company and the field of neurodiagnostics,” said Chris Landon, CEO of Natus. “This acquisition allows us to accelerate the adoption of cutting-edge AI technology that empowers healthcare providers and technologists with faster, more accurate EEG interpretation—improving patient outcomes worldwide. We are proud to unite our deep heritage in neuro care with Holberg’s groundbreaking innovation, creating a powerful force for advancing brain health for decades.”